Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Second Quarter Net Sales Increase 27% to $68.2 million Versus Q2 2020 On Track to Deliver Topline Results for Late-Stage Musculoskeletal Pipeline in Late Summer Company to Host Conference Call on...
-
MARIETTA, Ga., July 20, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
-
MIMEDX Applauds Dr. Laurencin on Receiving NAACP’s Highest Honor for His Contributions to Emerging Medical Sciences that Advance Human Healing MARIETTA, Ga., July 14, 2021 (GLOBE NEWSWIRE) --...
-
MARIETTA, Ga., June 28, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
-
MARIETTA, Ga, June 16, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
-
Proposed Mechanism Suggests Potential Path to Improve Outcomes in Clinical Applications where the Regulation of Excessive Fibrosis Can Promote a Normal Healing Response Complex Nature of MIMEDX dHACM...
-
Availability of EPIFIX Allografts Expected Early 2022 Approval Makes it Possible to Bring EPIFIX’s Healing Properties to as Many as 100,000 New Patients Annually MARIETTA, Ga., June 08, 2021 ...
-
MARIETTA, Ga., May 27, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
-
Deadline to Pre-Register Extended to May 26, 2021 at 10:00 a.m. Eastern Pre-Registration Required to Attend Annual Meeting Visit www.votemimedx.com for Instructions on How to Pre-Register ...
-
Vote FOR MIMEDX’s Experienced and Highly Qualified Directors and Governance Enhancement Proposals MARIETTA, Ga., May 12, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the...